Duobrii in Combination With Biologics

Part of paid clinical trials in East Windsor, New Jersey.

Sponsor
Psoriasis Treatment Center of Central New Jersey
Study ID
NCT04119102
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Duobrii — DRUG
    duobrii applied daily for 4 weeks followed by every other day for 4 weeks.

Study Details

12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks

Key Dates

Start date
Oct 14, 2019
Status verified
Apr 2020
Primary completion
Aug 1, 2020
Completion
Sep 1, 2020

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Open Label Duobrii
    Duobrii QD

Primary Outcome Measure

Body surface area improvement [ Time Frame: 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Psoriasis Treatment Center of Central New JerseyEast WindsorNew Jersey08520
Elise Nelson
[email protected]
609-443-4500
Jerry Bagel, MD (PRINCIPAL_INVESTIGATOR)
Brian Keegan, MD, PhD (SUB_INVESTIGATOR)
David Nieves, MD (SUB_INVESTIGATOR)
Alexa Hetzel, PA-C (SUB_INVESTIGATOR)

Find similar trials in East Windsor, NJ

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Psoriasis Treatment Center of Central New Jersey· East Windsor, NJ

Related Studies